We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMC icon
326
AMC Entertainment Holdings
AMC
$2.29B
$914K 0.02%
+114,421
New +$3.39M
IQV icon
327
IQVIA
IQV
$38.3B
$912K 0.02%
4,635
-11,000
-70% -$2.39M
JAZZ icon
328
Jazz Pharmaceuticals
JAZZ
$16.7B
$908K 0.02%
7,014
-7,200
-51% -$959K
ARDX icon
329
Ardelyx
ARDX
$1.2B
$898K 0.02%
+220,000
New +$858K
SPY icon
330
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$894K 0.02%
110,000
-339,000
-76% -$151M
HOG icon
331
PUT
Harley-Davidson
HOG
$2.67B
$875K 0.02%
+250,000
New +$8.7M
W icon
332
Wayfair
W
$14.3B
$848K 0.02%
14,000
+4,000
+40% +$278K
INFA
333
DELISTED
Informatica
INFA
$843K 0.02%
40,000
-85,000
-68% -$1.7M
SCYX icon
334
SCYNEXIS
SCYX
$51.6M
$835K 0.01%
45,752
-2,500
-5% -$59.7K
OSI
335
DELISTED
Osiris Acquisition Corp.
OSI
$832K 0.01%
80,570
– –
BHAC
336
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$829K 0.01%
78,575
– –
NKTR icon
337
Nektar Therapeutics
NKTR
$2.48B
$820K 0.01%
+91,750
New +$883K
EWTX icon
338
Edgewise Therapeutics
EWTX
$4.78B
$801K 0.01%
139,858
– –
THRD
339
DELISTED
Third Harmonic Bio
THRD
$799K 0.01%
+125,000
New +$764K
QTRX icon
340
Quanterix
QTRX
$180M
$792K 0.01%
29,200
-4,800
-14% -$119K
CRNX icon
341
Crinetics Pharmaceuticals
CRNX
$8.9B
$778K 0.01%
26,153
-30,000
-53% -$618K
INTU icon
342
Intuit
INTU
$88.1B
$766K 0.01%
+1,500
New +$759K
BCAB icon
343
BioAtla
BCAB
$5.53M
$753K 0.01%
8,854
+800
+10% +$102K
RZLT icon
344
Rezolute
RZLT
$453M
$736K 0.01%
557,307
+85,000
+18% +$139K
CABA icon
345
Cabaletta Bio
CABA
$450M
$736K 0.01%
48,332
-33,000
-41% -$451K
RIG icon
346
PUT
Transocean
RIG
$5.71B
$733K 0.01%
425,000
+25,000
+6% +$204K
FUSN
347
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$714K 0.01%
274,568
– –
ZM icon
348
Zoom
ZM
$29.7B
$699K 0.01%
10,000
-10,000
-50% -$694K
SILK
349
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$697K 0.01%
46,528
-10,000
-18% -$208K
RYTM icon
350
Rhythm Pharmaceuticals
RYTM
$7.72B
$688K 0.01%
+30,000
New +$672K
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.